- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Treatment B: abiraterone acetate
Total 762 results
-
Cougar Biotechnology, Inc.Completed
-
Janssen Research & Development, LLCCompleted
-
Janssen Research & Development, LLCCompleted
-
Janssen Research & Development, LLCCompleted
-
Cougar Biotechnology, Inc.Completed
-
Cougar Biotechnology, Inc.CompletedProstate NeoplasmsUnited Kingdom, United States
-
Fundación Pública Andaluza para la gestión de la...Completed
-
Janssen Research & Development, LLCCompletedHealthy ParticipantsUnited States
-
Assistance Publique - Hôpitaux de ParisJanssen, LPCompletedProstate CancerFrance
-
Memorial Sloan Kettering Cancer CenterUniversity of California, Los Angeles; Ferring Pharmaceuticals; Wayne State University and other collaboratorsCompleted
-
The Affiliated Hospital of Qingdao UniversityCompletedHealthy VolunteersChina
-
Cougar Biotechnology, Inc.Completed
-
AstraZenecaCompletedAdvanced Castrate-resistant Prostate Cancer CRPC | Squamous Non-Small Cell Lung Cancer sqNSCLC | Triple Negative Breast Cancer TNBCSpain, Canada, United States, United Kingdom
-
Universität des SaarlandesCompleted
-
Sun Pharmaceutical Industries LimitedCompletedProstate CancerUnited States
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Withdrawn
-
Jiangsu HengRui Medicine Co., Ltd.RecruitingMetastatic Castration-Resistant Prostate Cancer (mCRPC)Korea, Republic of, United States, Spain, France, Belgium, China, Taiwan, United Kingdom, Australia, Czechia, Hungary, Poland, Russian Federation
-
PfizerCompletedA Bioequivalence (BE) Study Comparing The Commericializable And Clinical Formulations Of PF-00299804Healthy VolunteersBelgium
-
Massachusetts General HospitalUnknown
-
Cougar Biotechnology, Inc.Completed
-
Johnson & Johnson Pharmaceutical Research & Development...Completed21-hydroxylase DeficiencyUnited States
-
Jiangsu HengRui Medicine Co., Ltd.Not yet recruitingHigh-volume, Metastatic, Hormone-sensitive Prostate Cancer (mHSPC)
-
Janssen Research & Development, LLCCompletedProstate NeoplasmsCanada, France, Poland, Ukraine, United Kingdom, China, Belgium, Spain, Argentina, Colombia, Israel, Mexico, Portugal, Bulgaria, Germany, Malaysia, Romania, South Africa, Turkey, Korea, Republic of, Japan, Australia, Netherlands, Sweden, New Zealand and more
-
Cougar Biotechnology, Inc.CompletedProstatic NeoplasmsUnited Kingdom
-
Han Xu, M.D., Ph.D., FAPCR, Sponsor-Investigator...Active, not recruitingProstate CancerUnited States
-
Zhongnan HospitalActive, not recruitingPharmacokinetic | Abiraterone Acetate | Plasma Concentration | Gene Polymorphism | Metabolic AnalysisChina
-
University of ChicagoNational Cancer Institute (NCI)CompletedCastration-resistant Prostate Cancer | Stage IV Prostate CancerSingapore, United States
-
Guangzhou University of Traditional Chinese MedicineCancer Institute and Hospital, Chinese Academy of Medical SciencesUnknown
-
University Health Network, TorontoCompletedCastration-resistant Prostate CancerCanada
-
ExelixisTerminatedProstatic Neoplasms | Prostate Cancer | Castration Resistant Prostate CancerUnited States
-
PfizerCompleted
-
PfizerCompleted
-
Hospices Civils de LyonCompletedAcquired Visual Field DefectsFrance
-
PfizerCompletedHealthyUnited States
-
Hongqian GuoAstraZeneca; Nanjing Chia-tai Tianqing PharmaceuticalRecruitingProstate Cancer | Metastatic Prostate Cancer | Prostate CarcinomaChina
-
PfizerCompleted
-
Novartis PharmaceuticalsCompleted
-
Arvinas Androgen Receptor, Inc.RecruitingProstate Cancer MetastaticUnited States
-
PfizerAstellas Pharma IncActive, not recruitingProstatic Neoplasms, Castration-ResistantUnited States
-
Aurelius OmlinUniversity Hospital, Basel, Switzerland; Cantonal Hospital of St. GallenTerminated
-
Cancer Research UKCompletedBreast CancerUnited Kingdom
-
Dana-Farber Cancer InstituteJanssen Research & Development, LLCActive, not recruitingCastration-resistant Prostate CancerUnited States
-
PfizerCompletedProstatic Neoplasms, Castration-ResistantUnited States
-
Jiangsu HengRui Medicine Co., Ltd.CompletedMetastatic Castration-resistant Prostate Cancer (mCRPC)China
-
University of California, San FranciscoJohnson & Johnson; Cougar Biotechnology, Inc.Completed
-
AstraZenecaParexelCompletedCoronary Artery DiseaseUnited Kingdom
-
Rennes University HospitalRecruiting
-
Sidney Kimmel Cancer Center at Thomas Jefferson...Millennium: The Takeda Oncology CompanyCompletedRecurrent Prostate Cancer | Hormone-resistant Prostate Cancer | Adenocarcinoma of the Prostate | Stage IV Prostate CancerUnited States
-
AbbVieCompleted